Graded Exposure (GEXP) in Vivo Versus Physiotherapy in Complex Regional Pain Syndrome Type I (CRPS-I)
Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Feb 28, 2008
Trial Information
Current as of May 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Diagnosis CRPS-I according to IASP criteria.
- • 2. Pain related (PHODA-LE-score ≥ 35 and PHODA-UE-score ≥ 32)
- • 3. Age between 18 and 65.
- • 4. Rehabilitation treatment has been indicated.
- Exclusion Criteria:
- • 1. Pregnancy.
- • 2. Insufficient fluency in Dutch.
- • 3. Generalized pain syndrome.
- • 4. Dystonia.
- • 5. Sympathectomy of the affected extremity.
- • 6. Psychopathology
- • 7. Involvement in a claim regarding the disease.
- • 8. Substance abuse.
- • 9. Symptoms on both upper or both lower extremities.
About Maastricht University Medical Center
Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Marielle Goossens, Dr.
Principal Investigator
Maastricht University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials